Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Bovine Insulin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4648452
    • |
  • 18 November, 2025
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Bovine Insulin market size was valued at US$ 3669 million in 2024 and is forecast to a readjusted size of USD 4452 million by 2031 with a CAGR of 2.8% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Bovine insulin is a protein hormone secreted by pancreatic beta cells in the bovine pancreas that regulates sugar metabolism. It belongs to the class of polypeptide substances. Its molecular structure consists of two peptide chains, A and B. Chain A contains 21 amino acids and chain B contains 30 amino acids. They are connected by disulfide bonds to form a double-chain molecule. It is one of the smallest proteins with a clear chemical structure. The hormone plays a role in lowering blood sugar by promoting the entry of glucose into cells and inhibiting glycogenolysis and gluconeogenesis, while participating in the regulation of fat and protein metabolism. Bovine insulin is similar in structure to human insulin, but there are two amino acid differences (alanine and valine at the 8th and 10th positions of the A chain, respectively), which may trigger an immune response. In the early days, due to biotechnology restrictions, bovine insulin was used as the main drug for the treatment of diabetes. Later, with the development of recombinant DNA technology, human insulin and insulin analogs gradually replaced its mainstream position due to lower immunogenicity and higher safety. Nowadays, bovine insulin is mostly used in scientific research.
This report is a detailed and comprehensive analysis for global Bovine Insulin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Bovine Insulin market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2020-2031
Global Bovine Insulin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2020-2031
Global Bovine Insulin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/mg), 2020-2031
Global Bovine Insulin market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (US$/mg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bovine Insulin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bovine Insulin market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Thermo Fisher Scientific, Novo Nordisk, Bio-Techne, MP Biomedicals, TargetMol, GenScript, APExBIO, Cell Applications, GeminiBio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Bovine Insulin market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Natural
Synthetic
Market segment by Application
Biomedical Research
Pharmaceutical Industry
Other
Major players covered
Merck
Thermo Fisher Scientific
Novo Nordisk
Bio-Techne
MP Biomedicals
TargetMol
GenScript
APExBIO
Cell Applications
GeminiBio
Tonghua Dongbao Pharmaceuticals
Jiangsu Wanbang Biochemical Pharmaceutical Group
Shenzhen Hanyu Pharmaceuticals
Shanghai Maokang Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Bovine Insulin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Bovine Insulin, with price, sales quantity, revenue, and global market share of Bovine Insulin from 2020 to 2025.
Chapter 3, the Bovine Insulin competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Bovine Insulin breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Bovine Insulin market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Bovine Insulin.
Chapter 14 and 15, to describe Bovine Insulin sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Bovine Insulin Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Natural
    • 1.3.3 Synthetic
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Bovine Insulin Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Biomedical Research
    • 1.4.3 Pharmaceutical Industry
    • 1.4.4 Other
  • 1.5 Global Bovine Insulin Market Size & Forecast
    • 1.5.1 Global Bovine Insulin Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Bovine Insulin Sales Quantity (2020-2031)
    • 1.5.3 Global Bovine Insulin Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Bovine Insulin Product and Services
    • 2.1.4 Merck Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Bovine Insulin Product and Services
    • 2.2.4 Thermo Fisher Scientific Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Novo Nordisk
    • 2.3.1 Novo Nordisk Details
    • 2.3.2 Novo Nordisk Major Business
    • 2.3.3 Novo Nordisk Bovine Insulin Product and Services
    • 2.3.4 Novo Nordisk Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Novo Nordisk Recent Developments/Updates
  • 2.4 Bio-Techne
    • 2.4.1 Bio-Techne Details
    • 2.4.2 Bio-Techne Major Business
    • 2.4.3 Bio-Techne Bovine Insulin Product and Services
    • 2.4.4 Bio-Techne Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Bio-Techne Recent Developments/Updates
  • 2.5 MP Biomedicals
    • 2.5.1 MP Biomedicals Details
    • 2.5.2 MP Biomedicals Major Business
    • 2.5.3 MP Biomedicals Bovine Insulin Product and Services
    • 2.5.4 MP Biomedicals Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 MP Biomedicals Recent Developments/Updates
  • 2.6 TargetMol
    • 2.6.1 TargetMol Details
    • 2.6.2 TargetMol Major Business
    • 2.6.3 TargetMol Bovine Insulin Product and Services
    • 2.6.4 TargetMol Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 TargetMol Recent Developments/Updates
  • 2.7 GenScript
    • 2.7.1 GenScript Details
    • 2.7.2 GenScript Major Business
    • 2.7.3 GenScript Bovine Insulin Product and Services
    • 2.7.4 GenScript Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 GenScript Recent Developments/Updates
  • 2.8 APExBIO
    • 2.8.1 APExBIO Details
    • 2.8.2 APExBIO Major Business
    • 2.8.3 APExBIO Bovine Insulin Product and Services
    • 2.8.4 APExBIO Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 APExBIO Recent Developments/Updates
  • 2.9 Cell Applications
    • 2.9.1 Cell Applications Details
    • 2.9.2 Cell Applications Major Business
    • 2.9.3 Cell Applications Bovine Insulin Product and Services
    • 2.9.4 Cell Applications Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cell Applications Recent Developments/Updates
  • 2.10 GeminiBio
    • 2.10.1 GeminiBio Details
    • 2.10.2 GeminiBio Major Business
    • 2.10.3 GeminiBio Bovine Insulin Product and Services
    • 2.10.4 GeminiBio Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 GeminiBio Recent Developments/Updates
  • 2.11 Tonghua Dongbao Pharmaceuticals
    • 2.11.1 Tonghua Dongbao Pharmaceuticals Details
    • 2.11.2 Tonghua Dongbao Pharmaceuticals Major Business
    • 2.11.3 Tonghua Dongbao Pharmaceuticals Bovine Insulin Product and Services
    • 2.11.4 Tonghua Dongbao Pharmaceuticals Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Tonghua Dongbao Pharmaceuticals Recent Developments/Updates
  • 2.12 Jiangsu Wanbang Biochemical Pharmaceutical Group
    • 2.12.1 Jiangsu Wanbang Biochemical Pharmaceutical Group Details
    • 2.12.2 Jiangsu Wanbang Biochemical Pharmaceutical Group Major Business
    • 2.12.3 Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Product and Services
    • 2.12.4 Jiangsu Wanbang Biochemical Pharmaceutical Group Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Jiangsu Wanbang Biochemical Pharmaceutical Group Recent Developments/Updates
  • 2.13 Shenzhen Hanyu Pharmaceuticals
    • 2.13.1 Shenzhen Hanyu Pharmaceuticals Details
    • 2.13.2 Shenzhen Hanyu Pharmaceuticals Major Business
    • 2.13.3 Shenzhen Hanyu Pharmaceuticals Bovine Insulin Product and Services
    • 2.13.4 Shenzhen Hanyu Pharmaceuticals Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Shenzhen Hanyu Pharmaceuticals Recent Developments/Updates
  • 2.14 Shanghai Maokang Biotechnology
    • 2.14.1 Shanghai Maokang Biotechnology Details
    • 2.14.2 Shanghai Maokang Biotechnology Major Business
    • 2.14.3 Shanghai Maokang Biotechnology Bovine Insulin Product and Services
    • 2.14.4 Shanghai Maokang Biotechnology Bovine Insulin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Shanghai Maokang Biotechnology Recent Developments/Updates

3 Competitive Environment: Bovine Insulin by Manufacturer

  • 3.1 Global Bovine Insulin Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Bovine Insulin Revenue by Manufacturer (2020-2025)
  • 3.3 Global Bovine Insulin Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Bovine Insulin by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Bovine Insulin Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Bovine Insulin Manufacturer Market Share in 2024
  • 3.5 Bovine Insulin Market: Overall Company Footprint Analysis
    • 3.5.1 Bovine Insulin Market: Region Footprint
    • 3.5.2 Bovine Insulin Market: Company Product Type Footprint
    • 3.5.3 Bovine Insulin Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Bovine Insulin Market Size by Region
    • 4.1.1 Global Bovine Insulin Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Bovine Insulin Consumption Value by Region (2020-2031)
    • 4.1.3 Global Bovine Insulin Average Price by Region (2020-2031)
  • 4.2 North America Bovine Insulin Consumption Value (2020-2031)
  • 4.3 Europe Bovine Insulin Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Bovine Insulin Consumption Value (2020-2031)
  • 4.5 South America Bovine Insulin Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Bovine Insulin Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Bovine Insulin Sales Quantity by Type (2020-2031)
  • 5.2 Global Bovine Insulin Consumption Value by Type (2020-2031)
  • 5.3 Global Bovine Insulin Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Bovine Insulin Sales Quantity by Application (2020-2031)
  • 6.2 Global Bovine Insulin Consumption Value by Application (2020-2031)
  • 6.3 Global Bovine Insulin Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Bovine Insulin Sales Quantity by Type (2020-2031)
  • 7.2 North America Bovine Insulin Sales Quantity by Application (2020-2031)
  • 7.3 North America Bovine Insulin Market Size by Country
    • 7.3.1 North America Bovine Insulin Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Bovine Insulin Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Bovine Insulin Sales Quantity by Type (2020-2031)
  • 8.2 Europe Bovine Insulin Sales Quantity by Application (2020-2031)
  • 8.3 Europe Bovine Insulin Market Size by Country
    • 8.3.1 Europe Bovine Insulin Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Bovine Insulin Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Bovine Insulin Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Bovine Insulin Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Bovine Insulin Market Size by Region
    • 9.3.1 Asia-Pacific Bovine Insulin Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Bovine Insulin Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Bovine Insulin Sales Quantity by Type (2020-2031)
  • 10.2 South America Bovine Insulin Sales Quantity by Application (2020-2031)
  • 10.3 South America Bovine Insulin Market Size by Country
    • 10.3.1 South America Bovine Insulin Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Bovine Insulin Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Bovine Insulin Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Bovine Insulin Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Bovine Insulin Market Size by Country
    • 11.3.1 Middle East & Africa Bovine Insulin Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Bovine Insulin Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Bovine Insulin Market Drivers
  • 12.2 Bovine Insulin Market Restraints
  • 12.3 Bovine Insulin Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Bovine Insulin and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Bovine Insulin
  • 13.3 Bovine Insulin Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Bovine Insulin Typical Distributors
  • 14.3 Bovine Insulin Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Bovine Insulin. Industry analysis & Market Report on Bovine Insulin is a syndicated market report, published as Global Bovine Insulin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Bovine Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo